首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
CLINICAL-SIGNIFICANCE OF DIFFERENCES IN BIOAVAILABILITY OF MEDROXYPROGESTERONE ACETATE PREPARATIONS
被引:6
|
作者
:
STOCKDALE, AD
论文数:
0
引用数:
0
h-index:
0
STOCKDALE, AD
ROSTOM, AY
论文数:
0
引用数:
0
h-index:
0
ROSTOM, AY
机构
:
来源
:
CLINICAL PHARMACOKINETICS
|
1989年
/ 16卷
/ 03期
关键词
:
D O I
:
10.2165/00003088-198916030-00001
中图分类号
:
R9 [药学];
学科分类号
:
1007 ;
摘要
:
引用
收藏
页码:129 / 133
页数:5
相关论文
共 50 条
[1]
COMPARATIVE BIOAVAILABILITY OF 2 MEDROXYPROGESTERONE ACETATE SUSPENSIONS
ANTAL, EJ
论文数:
0
引用数:
0
h-index:
0
ANTAL, EJ
DICK, CF
论文数:
0
引用数:
0
h-index:
0
DICK, CF
WRIGHT, CE
论文数:
0
引用数:
0
h-index:
0
WRIGHT, CE
WELSHMAN, IR
论文数:
0
引用数:
0
h-index:
0
WELSHMAN, IR
BLOCK, EM
论文数:
0
引用数:
0
h-index:
0
BLOCK, EM
INTERNATIONAL JOURNAL OF PHARMACEUTICS,
1989,
54
(01)
: 33
-
39
[2]
PHARMACOKINETICS AND BIOAVAILABILITY OF MEDROXYPROGESTERONE ACETATE IN THE DOG AND THE RAT
SMITH, D
论文数:
0
引用数:
0
h-index:
0
机构:
WYETH AYERST RES,DRUG SAFETY EVALUAT,CHAZY,NY 12921
WYETH AYERST RES,DRUG SAFETY EVALUAT,CHAZY,NY 12921
SMITH, D
ENEVER, R
论文数:
0
引用数:
0
h-index:
0
机构:
WYETH AYERST RES,DRUG SAFETY EVALUAT,CHAZY,NY 12921
WYETH AYERST RES,DRUG SAFETY EVALUAT,CHAZY,NY 12921
ENEVER, R
DEY, M
论文数:
0
引用数:
0
h-index:
0
机构:
WYETH AYERST RES,DRUG SAFETY EVALUAT,CHAZY,NY 12921
WYETH AYERST RES,DRUG SAFETY EVALUAT,CHAZY,NY 12921
DEY, M
LATTA, D
论文数:
0
引用数:
0
h-index:
0
机构:
WYETH AYERST RES,DRUG SAFETY EVALUAT,CHAZY,NY 12921
WYETH AYERST RES,DRUG SAFETY EVALUAT,CHAZY,NY 12921
LATTA, D
WEIERSTALL, R
论文数:
0
引用数:
0
h-index:
0
机构:
WYETH AYERST RES,DRUG SAFETY EVALUAT,CHAZY,NY 12921
WYETH AYERST RES,DRUG SAFETY EVALUAT,CHAZY,NY 12921
WEIERSTALL, R
BIOPHARMACEUTICS & DRUG DISPOSITION,
1993,
14
(04)
: 341
-
355
[3]
IMPROVED BIOAVAILABILITY OF A NEW ORAL PREPARATION OF MEDROXYPROGESTERONE ACETATE
ETIENNE, MC
论文数:
0
引用数:
0
h-index:
0
机构:
CHR BESANCON,F-25000 BESANCON,FRANCE
ETIENNE, MC
MILANO, G
论文数:
0
引用数:
0
h-index:
0
机构:
CHR BESANCON,F-25000 BESANCON,FRANCE
MILANO, G
RENE, N
论文数:
0
引用数:
0
h-index:
0
机构:
CHR BESANCON,F-25000 BESANCON,FRANCE
RENE, N
BENEDETTI, MS
论文数:
0
引用数:
0
h-index:
0
机构:
CHR BESANCON,F-25000 BESANCON,FRANCE
BENEDETTI, MS
EFTHYMIOPOULOS, C
论文数:
0
引用数:
0
h-index:
0
机构:
CHR BESANCON,F-25000 BESANCON,FRANCE
EFTHYMIOPOULOS, C
VOVAN, ML
论文数:
0
引用数:
0
h-index:
0
机构:
CHR BESANCON,F-25000 BESANCON,FRANCE
VOVAN, ML
HURTELOUP, P
论文数:
0
引用数:
0
h-index:
0
机构:
CHR BESANCON,F-25000 BESANCON,FRANCE
HURTELOUP, P
MONTCUQUET, P
论文数:
0
引用数:
0
h-index:
0
机构:
CHR BESANCON,F-25000 BESANCON,FRANCE
MONTCUQUET, P
FRENAY, M
论文数:
0
引用数:
0
h-index:
0
机构:
CHR BESANCON,F-25000 BESANCON,FRANCE
FRENAY, M
NAMER, M
论文数:
0
引用数:
0
h-index:
0
机构:
CHR BESANCON,F-25000 BESANCON,FRANCE
NAMER, M
JOURNAL OF PHARMACEUTICAL SCIENCES,
1991,
80
(12)
: 1130
-
1132
[4]
THE BIOAVAILABILITY OF AN ORALLY-ADMINISTERED MEDROXYPROGESTERONE ACETATE SUSPENSION
ANTAL, EJ
论文数:
0
引用数:
0
h-index:
0
ANTAL, EJ
GILLESPIE, WR
论文数:
0
引用数:
0
h-index:
0
GILLESPIE, WR
ALBERT, KS
论文数:
0
引用数:
0
h-index:
0
ALBERT, KS
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS,
1983,
21
(05)
: 257
-
259
[5]
DIFFERENCES IN THE BIOAVAILABILITY OF DIHYDROTACHYSTEROL PREPARATIONS
KOYTCHEV, R
论文数:
0
引用数:
0
h-index:
0
机构:
PHARMACOL RES CO BIOPHARM GMBH,BERLIN,GERMANY
KOYTCHEV, R
ALKEN, RG
论文数:
0
引用数:
0
h-index:
0
机构:
PHARMACOL RES CO BIOPHARM GMBH,BERLIN,GERMANY
ALKEN, RG
VAGADAY, M
论文数:
0
引用数:
0
h-index:
0
机构:
PHARMACOL RES CO BIOPHARM GMBH,BERLIN,GERMANY
VAGADAY, M
KUNTER, U
论文数:
0
引用数:
0
h-index:
0
机构:
PHARMACOL RES CO BIOPHARM GMBH,BERLIN,GERMANY
KUNTER, U
KIRKOV, V
论文数:
0
引用数:
0
h-index:
0
机构:
PHARMACOL RES CO BIOPHARM GMBH,BERLIN,GERMANY
KIRKOV, V
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY,
1994,
47
(01)
: 81
-
84
[6]
STATISTICAL SIGNIFICANCE AND CLINICAL-SIGNIFICANCE
LEHMANN, A
论文数:
0
引用数:
0
h-index:
0
LEHMANN, A
AGE AND AGEING,
1992,
21
(01)
: 72
-
72
[7]
ANTIBIOTIC PHARMACOKINETICS IN CYSTIC-FIBROSIS - DIFFERENCES AND CLINICAL-SIGNIFICANCE
DEGROOT, R
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WASHINGTON,CHILDRENS ORTHOPED HOSP & MED CTR,DIV INFECT DIS,4800 SAND POINT WAY NE,SEATTLE,WA 98105
DEGROOT, R
SMITH, AL
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WASHINGTON,CHILDRENS ORTHOPED HOSP & MED CTR,DIV INFECT DIS,4800 SAND POINT WAY NE,SEATTLE,WA 98105
SMITH, AL
CLINICAL PHARMACOKINETICS,
1987,
13
(04)
: 228
-
253
[8]
EFFECT OF INJECTION VOLUME ON THE BIOAVAILABILITY OF STERILE MEDROXYPROGESTERONE ACETATE SUSPENSION
WRIGHT, CE
论文数:
0
引用数:
0
h-index:
0
WRIGHT, CE
ANTAL, EJ
论文数:
0
引用数:
0
h-index:
0
ANTAL, EJ
GILLESPIE, WR
论文数:
0
引用数:
0
h-index:
0
GILLESPIE, WR
ALBERT, KS
论文数:
0
引用数:
0
h-index:
0
ALBERT, KS
CLINICAL PHARMACY,
1983,
2
(05):
: 435
-
438
[9]
BIOAVAILABILITY OF MEDROXYPROGESTERONE ACETATE FROM 3 ORAL DOSAGE FORMULATIONS
STALKER, DJ
论文数:
0
引用数:
0
h-index:
0
STALKER, DJ
WELSHMAN, IR
论文数:
0
引用数:
0
h-index:
0
WELSHMAN, IR
POLLOCK, SR
论文数:
0
引用数:
0
h-index:
0
POLLOCK, SR
CLINICAL THERAPEUTICS,
1992,
14
(04)
: 544
-
552
[10]
THE CLINICAL-SIGNIFICANCE OF CHANGE
REEVES, BC
论文数:
0
引用数:
0
h-index:
0
REEVES, BC
HILL, AR
论文数:
0
引用数:
0
h-index:
0
HILL, AR
ASPINALL, PA
论文数:
0
引用数:
0
h-index:
0
ASPINALL, PA
OPHTHALMIC AND PHYSIOLOGICAL OPTICS,
1987,
7
(04)
: 441
-
446
←
1
2
3
4
5
→